Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

NCT05443971 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Lung Non-Small Cell Carcinoma
Stage III Lung Cancer AJCC v8

Interventions

BIOLOGICAL: Durvalumab
RADIATION: Radiation Therapy
PROCEDURE: Biospecimen Collection

Sponsor

Mayo Clinic